Achiko AG Enters into a Convertible Note of Up to CHF $2 Million with Negma Group
ZURICH, Switzerland, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“the Company”) has entered into a new subordinated convertible loan transaction of up to CHF $2 million with Negma Group containing a conversion right into registered shares of the Company with a conversion period of 3 years.
The convertible loan transaction will close between January 1 and February 15, 2021 and comes attached with an issuance of 1,500,000 warrants in Negma Group’s favour. Each warrant confers the right to purchase one registered share of the Company, has an exercise period between the 30th and 365th day after the date of issuance of the warrants, and with an exercise price of CHF $0.35 (subject to customary adjustments).
This replaces the existing financing facility with Negma Group and is complementary to the Company’s recent announcements regarding updates to the capital increase of CHF 2.9 million in October and the recent announcement of the convertible note with Yorkville of USD $2.5 million.
“2020 has been critical for us in establishing solid foundations for Teman Sehat and Gumnuts,” said Steven Goh, CEO Achiko AG. “We’re grateful to everyone for their support and the recent transactions establishes the Company for an exciting 2021.”
ABOUT ACHIKO AG
We create solutions with a great user experience, for the transformation of the healthcare industry.
The development of our patent pending diagnostic testing kit for Covid-19 (Gumnuts) provides an easy and effective way to help people get the information they need. This is complemented by our mobile check-in app (Teman Sehat), enabling users to manage their diagnostic experiences on their own terms, safeguard their privacy, share experiences and find community.
We are headquartered in Zurich, with offices in Hong Kong, Jakarta, Singapore and Seoul. For more information, visit
Media contacts:
ACHIKO AG
Investor Relations
E:
Switzerland
Marcus Balogh
Farner Consulting Ltd.
E:
T: 7
Germany and Austria
Axel Mühlhaus / Dr Sönke Knop
edicto GmbH
E:
T: -51
DISCLAIMER
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
